Index Ventures, Novo A/S and Ventech have partially exited their investment in Funxional Therapeutics, following the company’s sale of its rights to lead anti-inflammatory drug FX 125L to German pharmaceuticals company Boehringer Ingelheim.
Sale of Italian printed circuit boards marks second exit of Milan-based GP’s Fund 3
Belgian VC held first close for debut vehicle on EUR 75m with commitments from PMV, EIF
Verium I SCS, which closed on CHF 120m, is the family office's first LP-backed fund
Informal talks held with potential bidders in the summer; EUR 60m debt line arranged last month